FR2429837A1 - Procede de preparation pure d'urokinase - Google Patents

Procede de preparation pure d'urokinase

Info

Publication number
FR2429837A1
FR2429837A1 FR7916757A FR7916757A FR2429837A1 FR 2429837 A1 FR2429837 A1 FR 2429837A1 FR 7916757 A FR7916757 A FR 7916757A FR 7916757 A FR7916757 A FR 7916757A FR 2429837 A1 FR2429837 A1 FR 2429837A1
Authority
FR
France
Prior art keywords
urokinase
pure
pure preparation
solution
matrix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7916757A
Other languages
English (en)
Other versions
FR2429837B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alpha Patent Ltd
Original Assignee
Alpha Patent Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alpha Patent Ltd filed Critical Alpha Patent Ltd
Publication of FR2429837A1 publication Critical patent/FR2429837A1/fr
Application granted granted Critical
Publication of FR2429837B1 publication Critical patent/FR2429837B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • C12N9/6456Plasminogen activators
    • C12N9/6462Plasminogen activators u-Plasminogen activator (3.4.21.73), i.e. urokinase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21Serine endopeptidases (3.4.21)
    • C12Y304/21073Serine endopeptidases (3.4.21) u-Plasminogen activator (3.4.21.73), i.e. urokinase
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/814Enzyme separation or purification
    • Y10S435/815Enzyme separation or purification by sorption

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La présente invention concerne un procédé de préparation pure et de concentration d'urokinase en partant d'une solution brute d'urokinase. La solution d'urokinase est mise au contact d'une matrice en substance solide poreuse à surface spécifique élevée, dans un milieu à pH >= 6. Sur la surface de la matrice on a immobilisé de l'aprotinine au moyen de composés chimiques covalents. Ensuite, on traite l'urokinase adsorbée par élution à pH =< 4,5, à l'aide d'un agent d'élution. Les solutions pures et très concentrées d'urokinase sont utilisées en médecine comme produit pour dissoudre les caillots de fibrine.
FR7916757A 1978-06-30 1979-06-28 Procede de preparation pure d'urokinase Granted FR2429837A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH719778A CH643297A5 (de) 1978-06-30 1978-06-30 Verfahren zur reindarstellung von urokinase.

Publications (2)

Publication Number Publication Date
FR2429837A1 true FR2429837A1 (fr) 1980-01-25
FR2429837B1 FR2429837B1 (fr) 1984-01-20

Family

ID=4321401

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7916757A Granted FR2429837A1 (fr) 1978-06-30 1979-06-28 Procede de preparation pure d'urokinase

Country Status (10)

Country Link
US (1) US4259447A (fr)
JP (1) JPS5832591B2 (fr)
AR (1) AR220202A1 (fr)
CH (1) CH643297A5 (fr)
DE (1) DE2924744C2 (fr)
FR (1) FR2429837A1 (fr)
GB (1) GB2025977B (fr)
IL (1) IL57596A (fr)
IT (1) IT1121914B (fr)
NL (2) NL185573C (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2121050B (en) * 1979-07-05 1986-03-26 Genentech Inc Preparation of functional human urokinase proteins
NL8003402A (nl) * 1980-06-11 1982-01-04 Leuven Res & Dev Vzw Nieuwe plasminogeen-activator en farmaceutisch preparaat met trombolytische werking.
US5112755A (en) * 1982-04-15 1992-05-12 Genentech, Inc. Preparation of functional human urokinase proteins
US4853330A (en) * 1983-04-07 1989-08-01 Genentech, Inc. Human tissue plasminogen activator
US4766075A (en) * 1982-07-14 1988-08-23 Genentech, Inc. Human tissue plasminogen activator
FI831484L (fi) * 1982-05-05 1983-11-06 Genentech Inc Plasminogen aktivator foer maenskovaevnad
ZA833174B (en) * 1982-05-05 1984-08-29 Genentech Inc Human tissue plasminogen activator
US5185259A (en) * 1982-05-05 1993-02-09 Genentech, Inc. Truncated human tissue plasminogen activator
US4525465A (en) * 1983-10-07 1985-06-25 Nippon Kayaku Kabushiki Kaisha Water-insoluble biospecific absorbent containing argininal derivative
EP0253331B1 (fr) * 1986-07-15 1994-10-19 Kowa Co. Ltd. Substance se liant à la thrombine et son procédé de préparation
US4920051A (en) * 1988-02-03 1990-04-24 Damon Biotech, Inc. Recovery of urokinase compounds
JP2002267642A (ja) * 2001-03-13 2002-09-18 Tosoh Corp アルカリ土類金属イオン測定用イオンクロマトグラフィー溶離液およびそれを用いたアルカリ土類金属イオン分析方法
WO2016201077A1 (fr) 2015-06-12 2016-12-15 Emory University Compositions de croissance et de survie pour des cellules capables de produire des anticorps et procédés associés
US11125757B2 (en) 2017-05-26 2021-09-21 Emory University Methods of culturing and characterizing antibody secreting cells
KR102277471B1 (ko) 2019-10-22 2021-07-14 주식회사 지니스 '혈관내 혈전' 용해제

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52105279A (en) * 1976-03-01 1977-09-03 Wakamoto Pharma Co Ltd Collfcting method of urokinase and novel absorbing agent used in said method

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3010074A (en) * 1959-02-25 1961-11-21 Raytheon Co Adjustable core transformer oscillator
US4165258A (en) * 1975-10-08 1979-08-21 University Of Pennsylvania Plasminogen activating enzyme-specific competitive inhibitor
DE2632221A1 (de) * 1976-07-16 1978-01-19 Frantisek Zdobinsky Diebstahlsicherungstafel fuer kraftfahrzeuge und fahrraeder
US4066506A (en) * 1976-10-08 1978-01-03 The United States Of America As Represented By The Secretary Of Health, Education And Welfare Method of separating and purifying two active forms of urokinase using affinity chromatography

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52105279A (en) * 1976-03-01 1977-09-03 Wakamoto Pharma Co Ltd Collfcting method of urokinase and novel absorbing agent used in said method

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CA1975 *
CA1976 *
CA1977 *

Also Published As

Publication number Publication date
IT7923835A0 (it) 1979-06-25
NL185573C (nl) 1990-05-16
IL57596A (en) 1982-12-31
GB2025977A (en) 1980-01-30
GB2025977B (en) 1982-09-29
NL185573B (nl) 1989-12-18
DE2924744C2 (de) 1982-09-16
CH643297A5 (de) 1984-05-30
JPS5523993A (en) 1980-02-20
IL57596A0 (en) 1979-10-31
NL7905045A (nl) 1980-01-03
DE2924744A1 (de) 1980-01-17
FR2429837B1 (fr) 1984-01-20
AR220202A1 (es) 1980-10-15
NL930096I1 (nl) 1993-10-01
JPS5832591B2 (ja) 1983-07-14
IT1121914B (it) 1986-04-23
US4259447A (en) 1981-03-31

Similar Documents

Publication Publication Date Title
FR2429837A1 (fr) Procede de preparation pure d&#39;urokinase
DZ473A1 (fr) Dérivés de l&#39;acide cis-endo-2-azabicyclo/3,3,o/-octane-3-carboxylique, procédé pour leur préparation, agents contenant ces dérivés et leur utilisation.
CA2029021A1 (fr) Alkoxysilanes contenant de la pyridine, lies a des supports inorganiques, et procedes pour leur utilisation permettant d&#39;eliminer et de concentrer des ions particuliers contenus dans des solution
GB1531558A (en) Compositions having affinity for hepatitis virus and method for hepatitis virus removal
CA2118602A1 (fr) Procede de fabrication d&#39;une solution aqueuse industrielle de chlorure de sodium
CLARK et al. Conversion of the active‐site cysteine residue of papain into a dehydro‐serine, a serine and a glycine residue
IE811513L (en) Benzisoselenazolones
DE3160618D1 (en) Liquid cold-stable titanium catalyst composition and process for its preparation
FR2430391A1 (fr) Procede pour separer l&#39;iode d&#39;un melange liquide contenant de l&#39;iode, de l&#39;acide iodhydrique et de l&#39;eau
FR2434162A1 (fr) Nouveaux derives de 4-amino-2-piperidino-quinazoline, leur procede de production et medicament les contenant
Siegel et al. The Proteolytic Enzymes of the K-1 Strain of Streptomyces griseus Obtained from a Commercial Preparation (Pronase): IV. STRUCTURE-FUNCTION STUDIES OF THE TWO SMALLEST SERINE ENDOPEPTIDASES; STABILIZATION BY GLYCEROL DURING REACTION WITH ACETIC ANHYDRIDE
FR2357518A1 (fr) Procede de preparation de cetones hydroxylees en a
FR2433525A1 (fr) Nouveaux derives d&#39;imidazole, leur procede de production et composition pharmaceutique les contenant
BE881827A (fr) Procede pour la purification de solutions acides contenant des metaux
OA07513A (fr) Nouveaux dérivés d&#39;acides (di) thiophosphoriques et-phospohoniques, procédé pour les préparer, produits en contenant et leur application en phytiatrie.
FR2393006A1 (fr) Procede de purification de l&#39;urokinase
AU662134B2 (en) Process for the enzymatic hydrolysis of a carboxylic acid derivative
BE901225A (fr) Nouveaux polyethers ioniques, leur procede de preparation et composition les contenant.
FR2450246A1 (fr) Procede de separation des isomeres optiques du 1-(o-methoxy-phenoxy)-3-isopropyl-amino-propane-2-ol et compositions pharmaceutiques contenant l&#39;antipode levogyre, utile notamment comme agent b-bloquant
JPS56501453A (fr)
DZ2913A1 (fr) Composition pharmaceutique concentrée liquide de sertraline et procédé pour sa préparation.
Lin et al. Two-step affinity chromatography. Model systems and an example using biotin-avidin binding and a fluoridolyzable linker
FR2366303A1 (fr) Procede de modification chimique de substances proteiniques, moyen approprie a ce procede et procede pour la preparation de ces substances
BE899953A (fr) Procede pour la preparation d&#39;un phase stationnaire pour la chromatographie et phase stationnaire ainsi obtenue.
FR2434198A1 (fr) Clarifiant pour la biere et procede en permettant la fabrication

Legal Events

Date Code Title Description
TP Transmission of property
CC Supplementary protection certificate (spc) laid open to the public (law of 25 june 1990)

Free format text: 92C0252, 920521

CB Supplementary protection certificate (spc) granted (law of 25 june 1990)

Free format text: 92C0251, 790628

CB Supplementary protection certificate (spc) granted (law of 25 june 1990)

Free format text: 92C0252, 790628

CL Concession to grant licences